HealthcareServices

Global Blood Plasma Derivatives Market Report 2026–2030: Data-Driven Growth Insights

February 20, 2026February 20, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the blood plasma derivatives market from 2026–2035 with trusted insights from The Business Research Company

What total market size is anticipated for the Blood Plasma Derivatives Market in 2030?

The blood plasma derivatives market size has experienced robust expansion over recent years. Forecasts indicate it will expand from $55.76 billion in 2025 to $60.76 billion in 2026, showing a compound annual growth rate (CAGR) of 9.0%. This historical growth can be linked to factors like the increasing diagnosis of rare blood disorders, the expansion of plasma collection programs, a rising demand for albumin therapies, enhancements in plasma fractionation techniques, and the growing usage of plasma in hospital settings.

The blood plasma derivatives market is projected to experience substantial expansion over the upcoming years, reaching $86.68 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.3%. This anticipated growth during the forecast period is primarily driven by factors such as the increasing prevalence of immunodeficiency diseases, escalating investments in plasma-derived therapeutics, the broadening of global plasma donation networks, a heightened emphasis on achieving self-sufficiency in plasma supply, and ongoing advancements in recombinant protein technologies. Key trends anticipated for the forecast timeframe encompass an escalating demand for immunoglobulin therapies, increasing acceptance of recombinant plasma products, the expansion of fractionation and purification technologies, a greater focus on pathogen reduction processes, and improvements in cold chain and plasma processing efficiency.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12107&type=smp

What Drivers Are Influencing Production Trends In The Blood Plasma Derivatives Market?

The rising occurrence of hemophilia is anticipated to fuel expansion within the blood plasma derivatives market. Hemophilia is defined as a hereditary bleeding disorder where the blood’s clotting ability is impaired, which can lead to spontaneous hemorrhages as well as bleeding post-injury or surgical procedures. For individuals experiencing hereditary or acquired hemostasis issues, treatments derived from blood plasma are effective in enhancing blood clotting. Specifically, factor VIII concentrates are used to treat hemophilia A, factor VIII/vWF concentrates for von Willebrand disease, and factor IX concentrates for hemophilia B. For instance, the World Federation of Hemophilia (WFH) Annual Global Survey (AGS) for 2024, reported in October 2025, indicated a 6% global increase in the identification of individuals with hemophilia, a 6% increase in those diagnosed with VWD, and a 9% increase in the detection of other inherited bleeding disorders. Consequently, the growing incidence of hemophilia is propelling the expansion of the blood plasma derivatives market.

Which Segments Are Gaining Traction In The Blood Plasma Derivatives Market?

The blood plasma derivatives market covered in this report is segmented –

1) By Type: Albumin, Factor VIII, Factor IX, Immunoglobulin, Hyperimmune Globulin, Other Types

2) By Application: Hemophilia, Hypogammaglobulinemia, Immunodeficiency Diseases, Von Willebrand’s Disease, Other Applications

3) By End-User: Hospitals, Clinics, Other End-Users

Subsegments:

1) By Albumin: Human Serum Albumin, Recombinant Albumin

2) By Factor VIII: Plasma-Derived Factor VIII, Recombinant Factor VIII

3) By Factor IX: Plasma-Derived Factor IX, Recombinant Factor IX

4) By Immunoglobulin: Intravenous Immunoglobulin (IVIG), Subcutaneous Immunoglobulin (SCIG)

5) By Hyperimmune Globulin: Specific Pathogen-Reduced Hyperimmune Globulin, Standard Hyperimmune Globulin

6) By Other Types: Fibrinogen, Clotting Factor Concentrates, Plasma-Derived Proteins

Which Competitive Trends Are Impacting The Structure Of The Blood Plasma Derivatives Market?

Leading companies in the blood plasma derivatives market are prioritizing supply chain innovation, such as with intravenous immunoglobulin, which supports the immune system by delivering functional antibodies to patients with immunodeficiency. Intravenous immunoglobulin (IVIg) refers to a drug formulated from purified antibodies collected from the plasma of thousands of healthy donors, used to modulate the immune system. For instance, in August 2025, Octapharma, a human protein products company based in Switzerland, focuses on plasma-derived and recombinant therapies. Under the UK Plasma for Medicines Programme, it launched Gamten 10% IVIg, an intravenous immunoglobulin (IVIg) product sourced from UK-donated human plasma, designed to offer immunoglobulin replacement therapy for patients experiencing primary or secondary immunodeficiency. Additionally, it also provides specialty therapies, including coagulation factors and critical care conditions.

Who Are The Primary Competitors In The Global Blood Plasma Derivatives Market?

Major companies operating in the blood plasma derivatives market are Bayer AG, Sanofi S.A., Takeda Pharmaceutical Company Limited, Baxter International Inc., CSL Limited, Meiji Group, Grifols S.A., Shire Pharmaceuticals Inc., GC Biopharma Corp, Emergent BioSolutions Inc., Shanghai Raas Blood Products Co Ltd., Kedrion S.p.A., Sanquin, Biotest AG, Bio Products Ltd., ADMA Biologics Inc., China Biologic Products Holdings Inc., BioIVT, PlasmaGen BioSciences Pvt. Ltd., Virchow Biotech Private Limited, LFB S.A., Intas Pharmaceuticals Ltd., Octapharma Plasma

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/blood-plasma-derivatives-global-market-report

Which Global Regions Are Shaping The Competitive Landscape Of The Blood Plasma Derivatives Market?

North America was the largest region in the blood plasma derivatives market in 2025. The regions covered in the blood plasma derivatives market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Blood Plasma Derivatives Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=12107&type=smp

Browse Through More Reports Similar to the Global Blood Plasma Derivatives Market 2026, By The Business Research Company

Plasma Powder Market Report 2026

https://www.thebusinessresearchcompany.com/report/plasma-powder-global-market-report

Therapeutic Plasma Exchange Market Report 2026

https://www.thebusinessresearchcompany.com/report/therapeutic-plasma-exchange-global-market-report

Plasma Protein Therapeutics Market Report 2026

https://www.thebusinessresearchcompany.com/report/plasma-protein-therapeutics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795